Quality of life analysis of patients undergoing immunotherapy for allergic rhinitis

Ear, Nose and Throat Journal

Volumn 76, Issue 8, 1997, Pages 528-536

  Fell, William R ^a,b   Mabry, Richard L ^a,b   Mabry, Cynthia S ^a,b  

^a UT Southwestern Medical Center ^*

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; ANTIBIOTIC AGENT; ANTIHISTAMINIC AGENT; ASTEMIZOLE; BECLOMETASONE DIPROPIONATE; CLEMASTINE FUMARATE; CORTISONE; CROMOGLYCATE DISODIUM; DECONGESTIVE AGENT; DEXAMETHASONE; DIMETAPP; FENTHION; FLUNISOLIDE; FLUTICASONE PROPIONATE; LORATADINE; METHYLPREDNISOLONE; PSEUDOEPHEDRINE; PSEUDOEPHEDRINE PLUS TRIPROLIDINE; STEROID; TERFENADINE; TRIAMCINOLONE ACETONIDE; UNCLASSIFIED DRUG;

ALLERGIC RHINITIS; ARTICLE; COST BENEFIT ANALYSIS; DRUG SAFETY; HUMAN; IMMUNOTHERAPY; MAJOR CLINICAL STUDY; QUALITY OF LIFE; RADIOALLERGOSORBENT TEST; WELLBEING;

EID: 0030874852     PISSN: 01455613     EISSN: None     Source Type: Journal    
DOI: 10.1177/014556139707600809     Document Type: Article

References (13)

1. Juniper EF. What is rhinitis disease? Quality of life measures. Presented at the symposium Respecting Rhinitis and Reducing Rhinorrhea, November 10, 1995, American College of Allergy, Asthma and Immunology, Dallas, Texas
2. Sibbald B, Rink E. Epidemiology of seasonal and perennial rhinitis: Clinical presentation and medical history. Thorax 1991; 46:895-901.
3. Squillace SP. Environmental control. Otolaryngol Head Neck Surg 1992(Suppl); 107(6):831-4.
4. Krause HF Antihistamines and decongestants. Otolaryngol Head Neck Surg 1992 (Suppl); 107(6):835-40.
5. King HC. Mast cell stabilizers. Otolaryngol Head Neck Surg 1992 (Suppl); 107(6):841-4
6. Mabry RL. Corticosteroids in the management of upper respiratory allergy: The emerging role of steroid nasal sprays. Otolaryngol Head Neck Surg 1992 (Suppl): 107(6):855-60.
7. Gordon BR. Immunotherapy Rationale and mechanisms. Otolaryngol Head Neck Surg 1992 (Suppl); 107(6):861-5.
8. Mabry RL. Blending skin endpoint titration and in vitro methods in clinical practice. Otolaryngol Clin N Am 1992; 25-61-70.
9. Ohman JL. Allergen immunotherapy: Review of efficacy and current practice. Med Clin N Am 1992; 76:977-88.
10. Fadal RG, Nalebuff DJ. A study of optimum dose immunotherapy in pharmacological treatment failures. Arch Otolaryngol 1980; 106:38-43.
11. Bousquet JB, Bullinger M, Fayol C, et al. Assessment of quality of life in patients with perennial allergic rhinitis with the French version of the SF-36 Health Status Questionnaire. J Allergy Clin Immunol 1994; 94(2) 182-8.
12. Juniper EF, Guyatt GH, Dolovich J. Assessment of quality of life in adolescents with allergic rhinoconjunctivitis: Development and testing of a questionnaire for clinical trials. J Allergy Clin Immunol 1994; 93(2):413-21.
13. Mabry RL, Mabry CS. Significance of borderline levels of specific IgE obtained by FAST-plus assay. Otolaryngol Head Neck Surg 1992; 106:250-3.